The PI3K/AKT pathway is activated by HGF in NT2D1 non‐seminoma cells and has a role in the modulation of their malignant behavior
Overactivation of the c‐MET/HGF system is a feature of many cancers. We previously reported that type II testicular germ cell tumor (TGCT) cells express the c‐MET receptor, forming non‐seminomatous lesions that are more positive compared with seminomatous ones. Notably, we also demonstrated that NT2D1 non‐seminomatous cells (derived from an embryonal carcinoma lesion) increase their proliferation, migration, and invasion in response to HGF.